Cytokinetics Inc CYTK
7 insiders sold $24.5M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $24.8M sold on 30 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Robert I. Blum President & CEO, Director |
- | $12.8M | Nov 2, 2026 |
| Andrew Callos EVP, Chief Commercial Officer |
- | $4.2M | Aug 31, 2026 |
| Sung Lee EVP, Chief Financial Officer |
- | $3.6M | Jul 1, 2026 |
| Fady Ibraham Malik EVP Research & Development |
- | $2.5M | Nov 3, 2026 |
| B. Lynne Parshall Director |
- | $1.0M | Nov 9, 2026 |
| Edward M. MD Kaye Director |
- | $223K | Jun 1, 2026 |
| Robert E. Landry Director |
- | $147K | Sep 15, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 37 open-market sales by officers and directors, 11 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 9, 2026 | B. Lynne Parshall | Sale (10b5-1) | -2,445 | 132K |
| Nov 9, 2026 | B. Lynne Parshall | Sale (10b5-1) | -2,555 | 141K |
| Nov 3, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 220K |
| Nov 2, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 471K |
| Oct 20, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 224K |
| Oct 12, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 472K |
| Oct 6, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 215K |
| Sep 28, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 491K |
| Sep 22, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 239K |
| Sep 15, 2026 | Robert I. Blum (indirect) | Sale (10b5-1) | -97,926 | 6.8M |
| Sep 15, 2026 | Robert E. Landry | Sale (10b5-1) | -1,000 | 72K |
| Sep 14, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 551K |
| Sep 11, 2026 | Robert E. Landry | Sale (10b5-1) | -1,000 | 75K |
| Sep 8, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 264K |
| Sep 1, 2026 | B. Lynne Parshall | Sale (10b5-1) | -5,000 | 357K |
| Aug 31, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 527K |
| Aug 31, 2026 | Andrew Callos | Sale (10b5-1) | -10,000 | 702K |
| Aug 18, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 265K |
| Aug 10, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 576K |
| Jul 30, 2026 | Andrew Callos | Sale (10b5-1) | -14,000 | 1.1M |
| Jul 27, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 607K |
| Jul 21, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 282K |
| Jul 13, 2026 | Robert I. Blum | Sale (10b5-1) | -10 | 820 |
| Jul 13, 2026 | Robert I. Blum | Sale (10b5-1) | -7,490 | 614K |
| Jul 7, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 303K |
| Jul 1, 2026 | Sung Lee | Sale (10b5-1) | -1,112 | 98K |
| Jul 1, 2026 | Andrew Callos | Sale (10b5-1) | -15,000 | 1.3M |
| Jul 1, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 637K |
| Jun 29, 2026 | Sung Lee | Sale (10b5-1) | -3,134 | 266K |
| Jun 24, 2026 | Sung Lee | Sale (10b5-1) | -38,730 | 3.2M |
| Jun 23, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 278K |
| Jun 15, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 528K |
| Jun 9, 2026 | Fady Ibraham Malik | Sale (10b5-1) | -3,500 | 238K |
| Jun 1, 2026 | B. Lynne Parshall | Sale (10b5-1) | -5,000 | 370K |
| Jun 1, 2026 | Andrew Callos | Sale (10b5-1) | -15,000 | 1.1M |
| Jun 1, 2026 | Edward M. MD Kaye | Sale (10b5-1) | -2,933 | 223K |
| May 27, 2026 | Robert I. Blum | Sale (10b5-1) | -7,500 | 579K |
Show the other 22 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CYTK/export.csv") into a cell.